BTIG Initiates Coverage On Tiziana Life Sciences with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsInitiationPrice Target
BTIG analyst Thomas Shrader initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Buy rating and announces Price Target of $7.
BTIG analyst Thomas Shrader initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Buy rating and announces Price Target of $7.